ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,218Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1442

$1.32M Total Retail Price of All Prescriptions

Rank: 10 out of 1442

804 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 804 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

2% of this provider’s 804 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 19,614 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CARVEDILOL 1,424 1,319 1 8
METOPROLOL SUCCINATE 1,410 1,298 2 1
LOSARTAN POTASSIUM 1,408 1,306 3 13
AMLODIPINE BESYLATE 1,297 1,237 4 3
SIMVASTATIN 983 851 5 2
FUROSEMIDE 645 611 6 5
CLOPIDOGREL 482 465 7 12
CRESTOR 481 435 8 10
PLAVIX 480 441 9 14
LISINOPRIL 427 347 10 7
OMEPRAZOLE 426 390 11 21
ISOSORBIDE MONONITRATE ER 425 396 12 17
ATENOLOL 406 327 13 11
METFORMIN HCL 405 396 14 26
DIOVAN 381 364 15 19
PROPRANOLOL HCL 365 328 16 116
LOSARTAN-HYDROCHLOROTHIAZIDE 350 326 17 30
ZOLPIDEM TARTRATE 340 320 18 25
WARFARIN SODIUM 339 327 19 9
DIGOXIN 337 318 20 15
METOPROLOL TARTRATE 310 265 21 6
ATORVASTATIN CALCIUM 266 255 22 4
LOVAZA 253 230 23 37
NEXIUM 237 231 24 34
POTASSIUM CHLORIDE 234 230 25 33
JANUVIA 199 199 26 45
RANITIDINE HCL 193 162 27 64
BENICAR 191 190 28 61
FLUTICASONE PROPIONATE 162 144 29 99
TAMSULOSIN HCL 161 160 30 38
HYDRALAZINE HCL 159 140 31 48
RAMIPRIL 157 141 32 18
ENALAPRIL MALEATE 150 100 33 23
ALENDRONATE SODIUM 137 137 34 46
DIOVAN HCT 135 135 35 35
LIDODERM 127 127 36 76
FINASTERIDE 126 126 37 87
GLIPIZIDE XL 121 110 38 107
EVISTA 119 118 39 73
TRILIPIX 116 115 40 104
LIPITOR 116 109 40 24
LEVOTHYROXINE SODIUM 112 112 42 22
DONEPEZIL HCL 111 111 43 62
SPIRIVA 109 94 44 95
TRICOR 101 86 45 100
SERTRALINE HCL 98 98 46 58
ALLOPURINOL 97 97 47 47
JANUMET 92 91 48 109
AMMONIUM LACTATE 84 84 49 156
NITROGLYCERIN PATCH 82 69 50 65
ACTOS 78 78 51 110
GLIPIZIDE ER 75 75 52 161
MECLIZINE HCL 74 73 53 83
DOXAZOSIN MESYLATE 74 74 53 69
FENOFIBRATE 73 68 55 82
GEMFIBROZIL 71 68 56 172
XARELTO 70 70 57 74
AZITHROMYCIN 69 62 58 56
ONGLYZA 62 62 59 169
NIFEDIPINE ER 59 59 60 39
SPIRONOLACTONE 59 56 60 28
SINGULAIR 56 49 62 93
PRADAXA 56 56 62 27
AMIODARONE HCL 55 51 64 49
TOPROL XL 54 52 65 51
FLUDROCORTISONE ACETATE 54 18 65 220
CREON 53 53 67 189
BENICAR HCT 53 53 67 86
CLOTRIMAZOLE-BETAMETHASONE 51 51 69 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.